Intellia Therapeutics (NTLA) Enterprise Value Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.43% |
| Dec 31, 2025 | 5.51% |
| Sep 30, 2025 | -4.61% |
| Jun 30, 2025 | -1.02% |
| Mar 31, 2025 | -15.02% |
| Dec 31, 2024 | -16.55% |
| Sep 30, 2024 | -18.14% |
| Jun 30, 2024 | -20.58% |
| Mar 31, 2024 | -75.82% |
| Dec 31, 2023 | -23.77% |
| Sep 30, 2023 | -23.86% |
| Jun 30, 2023 | -24.34% |
| Mar 31, 2023 | -23.29% |
| Dec 31, 2022 | -28.48% |
| Sep 30, 2022 | -30.09% |
| Jun 30, 2022 | -29.39% |
| Mar 31, 2022 | -27.13% |
| Dec 31, 2021 | -22.42% |
| Sep 30, 2021 | -22.40% |
| Jun 30, 2021 | -11.96% |
| Mar 31, 2021 | -55.52% |
| Dec 31, 2020 | -51.11% |
| Sep 30, 2020 | -37.63% |
| Jun 30, 2020 | -85.73% |
| Mar 31, 2020 | -68.40% |